An Integrative Eight-Dimensional Nonlinear Dynamical Model for Polycystic Ovary Syndrome Management: First-Principles Derivation, Global Asymptotic Stability Analysis, Optimal Control, Bayesian Inference, Sensitivity Analysis, and Translational Framework

Polycystic ovary syndrome (PCOS) is the most prevalent heterogeneous endocrine-metabolic-reproductive disorder among reproductive-age women, with a global prevalence of 8--13\% and substantial phenotypic variability across ethnic groups and diagnostic criteria (Rotterdam, NIH, AES) \citep{Teede2018, Teede2023, Azziz2016}. The syndrome is mechanistically driven by intertwined hyperandrogenism, insulin resistance (affecting 50--90\% of patients), ovulatory dysfunction, polycystic ovarian morphology, chronic low-grade systemic inflammation, hypothalamic-pituitary-ovarian axis dysregulation, and gut microbiome dysbiosis characterized by reduced Shannon diversity, depleted SCFA-producing taxa, and altered bile-acid metabolism \citep{Teede2018, Qi2019, Torres2018, Lindheim2017}. Conventional mono-therapeutic or dual-axis strategies (lifestyle modification, metformin, clomiphene citrate, letrozole, oral contraceptives) achieve remission rates of 40--66\% and fertility restoration below 60\%, with high relapse upon discontinuation and limited impact on long-term cardiometabolic risk \citep{Teede2018, Legro2014, Thessaloniki2008}. Recent causal evidence from fecal microbiota transplantation (FMT) in germ-free and antibiotic-treated rodent models demonstrates that transplantation of PCOS-patient-derived microbiota can induce metabolic dysfunction and ovarian abnormalities, while healthy microbiota transplantation shows therapeutic potential \citep{Qi2019, Torres2018, Lindheim2017}. Nutrigenomic and untargeted metabolomic investigations reveal gene--diet interactions involving variants in \textit{INSR}, \textit{CYP11A1}, \textit{FTO}, and \textit{PPARG}, along with consistent perturbations in branched-chain amino acids, aromatic amino acids, pyruvate, lactate, bile acids, and lipid subclasses that sustain a self-reinforcing disease state \citep{Insenser2018, Zhao2020, Escobar-Morreale2018}. Systems-biology network pharmacology has identified multi-target hubs converging on PI3K/Akt/mTOR, TNF-\alpha/NF-\kappaB, PPAR-\gamma, and AMPK pathways \citep{Zhang2020, Wang2019, Liu2021}. Previous dynamical-systems approaches have employed stochastic ODEs, fractional-order models, and semi-mechanistic frameworks, but these remain limited in scope and lack explicit multi-disciplinary control integration \citep{Mari2019, Bergman2019, Cobelli2019}. Artificial-intelligence applications achieve high diagnostic accuracy but have not been embedded within closed-loop control architectures \citep{Dalmia2021, Ghosh2022, Bhardwaj2020}.This study develops an eight-dimensional nonlinear ordinary differential equation (ODE) model that integrates precision endocrinology, nutrigenomics and metabolomics, gut microbiome engineering, systems-biology network pharmacology, and AI-driven reinforcement-learning personalization into a single closed-loop framework. The model is derived from first principles of mass-action kinetics and Hill-type receptor cooperativity, with explicit state vector \mathbf{x}(t) = [A,I,E,O,M,H,C,D]^\top representing normalized androgen, insulin, estrogen, ovulation index, microbiome Shannon diversity, hypothalamic GnRH pulse frequency, systemic inflammation index, and adiposity index, respectively. The control matrix \mathbf{B} \in \mathbb{R}^{8 \times 8} (Table~\ref{tab:B}) maps each disciplinary intervention to state perturbations. All 32 model parameters are sourced exclusively from published meta-analyses, human cohort studies, and mechanistic experiments, with explicit uncertainty ranges for sensitivity testing. Existence, uniqueness, and continuous dependence of solutions are guaranteed by the Picard--Lindelöf theorem on the compact positively invariant domain \mathcal{D} = [0,2]^8. Global asymptotic stability of the healthy attractor \mathbf{x}^* is rigorously proven via the direct Lyapunov method, with complete algebraic derivation of \dot{V} and explicit bounding of all nonlinear cross-terms. Optimal control trajectories are synthesized via Pontryagin's minimum principle, and reinforcement learning is employed for real-time personalization of the AI-driven control input. Hierarchical Bayesian inference with literature-anchored priors, global Sobol sensitivity analysis, stochastic extension via Itô calculus, and structural identifiability analysis via differential algebra are provided. The complete, reproducible Python 3.12 implementation is embedded. \textbf{Critical transparency statement:} This model is purely theoretical and computational; all predictions are derived from in-silico simulations calibrated to published literature parameters. Prospective clinical validation with real patient data constitutes essential future work before any translational application.